Needling vs. microneedling plus light therapy for vitiligo
Part of Skin clinical trials.
This trial compares two types of needle treatments (needling and microneedling) combined with light therapy to see which works better for people with vitiligo that has lasted more than a year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 60 years old
- You have had vitiligo for more than 1 year
- You do not have a history of keloids (raised, thick scars) or hypertrophic scarring
- You do not have a bleeding disorder, clotting problem, or take blood-thinning medications
- No active infection at the skin area to be treated
- You have not received any systemic (pill or injection) treatment for vitiligo in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment for non-segmental vitiligo that uses a special liquid made from stem cells, applied through tiny needle pricks or small injections, alongside standard light therapy. It may help restore pigment to white patches with fewer side effects than traditional treatments.
This trial tests whether a combination of micro-needling (tiny needles that create microscopic wounds to stimulate skin repair) and an anti-inflammatory ointment called crisaborole can help repigment white patches caused by stable vitiligo. It may be beneficial if your vitiligo has been stable and not spreading.
This trial tests whether adding a type of light therapy (narrow-band UVB) to a daily pill called ritlecitinib works better than the pill alone for treating vitiligo. It may help if you have non-segmental vitiligo covering a moderate amount of skin.
This study tests a combination of narrowband UVB light therapy and steroid cream to see how it affects the immune system in people with vitiligo. It may help reduce the white patches by calming the immune response.
This trial tests a new medicine called GR2301, given as an injection, combined with light therapy, to see if it can help people with vitiligo. It aims to improve skin color in affected areas, especially on the face.
This study tests whether adding a pill called apremilast to narrowband UVB light therapy works better than light therapy alone for vitiligo. It may help repigment the skin more effectively.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.